New vaccine aims to shield kids from 24 pneumococcal strains

NCT ID NCT07300644

First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 10 times

Summary

This study tests a new vaccine (PCV24) that protects against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. About 420 healthy children aged 2 months to 5 years will receive either the new vaccine or an existing one to compare safety and immune response. The goal is to see if the new vaccine is safe and triggers strong protection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qichun District Center for Disease Prevention and Control

    RECRUITING

    Huanggang, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xian'an District Center for Disease Prevention and Control

    RECRUITING

    Xianning, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiangzhou District Center for Disease Prevention and Control

    RECRUITING

    Xiangyang, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.